Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
91.96%
Operating Margin
56.41%
Net Margin
53.50%
Efficiency Metrics
Revenue per Expense Ratio
2.29
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
78.12%
Income Tax Rate
0.00%
EPS
5.8200000000
Balance Sheet Analysis
Current Ratio
1.06
Cash Ratio
1.06
Working Capital
$8.07M
Debt to Equity
0.15
Debt to Assets
12.65%
Equity Ratio
81.68%
Cash Flow Analysis
Operating Cash Flow Ratio
82.56%
Free Cash Flow Ratio
34.07%
CapEx to Revenue
48.49%
Dividends Paid
$204.06M
Stock Buybacks
$568.00K
Total Shareholder Returns
$204.63M
Cash Position Change
59.98%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 7.64%
Detailed Growth Metrics
Core Performance
Revenue
11.99%
Net Income
7.26%
EPS
4.49%
Operating Income
2.93%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
11.19%
Operating Cash Flow
9.15%
Free Cash Flow
282.86%
Balance Sheet Health
Assets
-0.98%
Debt
-0.20%
Book Value per Share
-2.71%
Inventory
0.00%
Shareholder Returns
Dividends per Share
7.64%
Shares Outstanding
2.31%
Long Term Trends
3Y Revenue/Share
84.01%
5Y Revenue/Share
434.08%
3Y Dividend/Share
84.62%
5Y Dividend/Share
552.58%